Novo – Today Stock Markets News

FDA says Novo Nordisk’s obesity pill TV ad includes misleading claims

Novo Nordisk sues Hims & Hers over compounded obesity drugs

Next steps for Eli Lilly, Novo Nordisk, Pfizer

Novo Nordisk, Pfizer execs weigh in

Novo Nordisk shares rise after Wegovy obesity pill launch

2026 is the year of obesity pills from Novo Nordisk, Eli Lilly

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Novo Nordisk shares fall after Alzheimer’s drug trial fails to hit target